ArticlePharmaceutics2021

Novel Multitarget Hydroxamic Acids with a Natural Origin CAP Group against Alzheimer's Disease: Synthesis, Docking and Biological Evaluation.

Margarita Neganova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.